In fact, The Cancer Genome Atlas (TCGA) study, including the Pan-Cancer project, identifies TP53 gene as the most significantly mutated gene in human cancers, resulting in perturbation of replication checkpoint function (2–5). This evidence concerns the gene TP53 and cancer.